Literature DB >> 17262906

Congenital muscular dystrophy: mini-agrin delivers in mice.

S Meinen, M A Ruegg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17262906     DOI： 10.1038/sj.gt.3302668

Source DB:  PubMed          Journal:  Gene Ther        ISSN： 0969-7128            Impact factor:   5.250


× No keyword cloud information.
  4 in total

1.  Muscular dystrophy meets protein biochemistry, the mother of invention.

Authors:  Steven D Funk; Jeffrey H Miner
Journal:  J Clin Invest       Date:  2017-02-20       Impact factor: 14.808

2.  Linker molecules between laminins and dystroglycan ameliorate laminin-alpha2-deficient muscular dystrophy at all disease stages.

Authors:  Sarina Meinen; Patrizia Barzaghi; Shuo Lin; Hanns Lochmüller; Markus A Ruegg
Journal:  J Cell Biol       Date:  2007-03-26       Impact factor: 10.539

3.  Mesoangioblast delivery of miniagrin ameliorates murine model of merosin-deficient congenital muscular dystrophy type 1A.

Authors:  Teuta Domi; Emanuela Porrello; Daniele Velardo; Alessia Capotondo; Alessandra Biffi; Rossana Tonlorenzi; Stefano Amadio; Alessandro Ambrosi; Yuko Miyagoe-Suzuki; Shin'ichi Takeda; Markus A Ruegg; Stefano Carlo Previtali
Journal:  Skelet Muscle       Date:  2015-09-03       Impact factor: 4.912

4.  Amelioration of Muscle and Nerve Pathology in LAMA2 Muscular Dystrophy by AAV9-Mini-Agrin.

Authors:  Chunping Qiao; Yi Dai; Viktoriya D Nikolova; Quan Jin; Jianbin Li; Bin Xiao; Juan Li; Sheryl S Moy; Xiao Xiao
Journal:  Mol Ther Methods Clin Dev       Date:  2018-01-31       Impact factor: 6.698
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.